BiotechTube
Home/Iterion Therapeutics/Laurence Watts
LW

Laurence Watts

Investor Relations Contact (New Street IR)

Iterion Therapeutics

Therapeutic Areas

Oncology

Iterion Therapeutics Pipeline

DrugIndicationPhase
TegavivintAdvanced Hepatocellular Carcinoma (HCC) with Wnt/β-catenin mutationsPhase 1b/2a

Leadership Team at Iterion Therapeutics

ML
Madeleine Lu
General Inquiries Contact
RW
Ryan Walker
Media Contact (RJ Walker Co.)
View full Iterion Therapeutics profile